M. V. Pomytkina, E. Bakhrushina, P. Sakharova, P. D. Konogorova, N. Demina
{"title":"开发用于切除术后治疗的原位牙科植入物的意义(综述)","authors":"M. V. Pomytkina, E. Bakhrushina, P. Sakharova, P. D. Konogorova, N. Demina","doi":"10.33380/2305-2066-2024-13-1-1462","DOIUrl":null,"url":null,"abstract":"Introduction. The problem of pain relief after surgery is relevant in modern dentistry, as pain control is an important part of treatment. In addition to anesthesia, there are other problems of post-resection therapy such as bleeding from the wound and inflammation. Modern dental practice does not have a targeted delivery system or a medical product with analgesic, anti-inflammatory, anesthetic or hemostatic action, which ensures high adherence of patients to the ongoing post-resection therapy.Text. To solve this problem, it can be proposed to develop an in situ implant – a dosage form that is formed directly at the injection site, in the alveolar socket. Targeted delivery system has advantages: no need to use a medical dressing material; no risk of secondary contamination; dosing accuracy and target delivery to the lesion locus; high mucoadhesion to the site of application; the duration of the active ingredient release and others. The purpose of the review is to substantiate the possibility and relevance of developing a new in situ implant system for use in dental post-resection practice. The study was conducted on the main databases of publications (Scopus, Web of Science, PubMed and others), and patent search database on materials published from 2000 to the present. The study describes the currently existing in situ systems for dental problems, which could be a prototype of systems for delivering an anesthetic directly to the tooth socket, the polymers used to create them and the possibility of releasing drugs, and also characterizes existing drugs for the pain relief (applied both locally and for systemic action), in comparison with in situ systems, which have certain advantages and great potential for development.Conclusion. Based on the results of the work, a conclusion about the possibility of pharmaceutical development of dental in situ implants was made, and the most promising polymers for phase transition in the alveolar socket were identified.","PeriodicalId":11259,"journal":{"name":"Drug development & registration","volume":"16 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Relevance of the Development of Dental In situ Implant for Post-resection Therapy (Review)\",\"authors\":\"M. V. Pomytkina, E. Bakhrushina, P. Sakharova, P. D. Konogorova, N. Demina\",\"doi\":\"10.33380/2305-2066-2024-13-1-1462\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction. The problem of pain relief after surgery is relevant in modern dentistry, as pain control is an important part of treatment. In addition to anesthesia, there are other problems of post-resection therapy such as bleeding from the wound and inflammation. Modern dental practice does not have a targeted delivery system or a medical product with analgesic, anti-inflammatory, anesthetic or hemostatic action, which ensures high adherence of patients to the ongoing post-resection therapy.Text. To solve this problem, it can be proposed to develop an in situ implant – a dosage form that is formed directly at the injection site, in the alveolar socket. Targeted delivery system has advantages: no need to use a medical dressing material; no risk of secondary contamination; dosing accuracy and target delivery to the lesion locus; high mucoadhesion to the site of application; the duration of the active ingredient release and others. The purpose of the review is to substantiate the possibility and relevance of developing a new in situ implant system for use in dental post-resection practice. The study was conducted on the main databases of publications (Scopus, Web of Science, PubMed and others), and patent search database on materials published from 2000 to the present. The study describes the currently existing in situ systems for dental problems, which could be a prototype of systems for delivering an anesthetic directly to the tooth socket, the polymers used to create them and the possibility of releasing drugs, and also characterizes existing drugs for the pain relief (applied both locally and for systemic action), in comparison with in situ systems, which have certain advantages and great potential for development.Conclusion. Based on the results of the work, a conclusion about the possibility of pharmaceutical development of dental in situ implants was made, and the most promising polymers for phase transition in the alveolar socket were identified.\",\"PeriodicalId\":11259,\"journal\":{\"name\":\"Drug development & registration\",\"volume\":\"16 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug development & registration\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33380/2305-2066-2024-13-1-1462\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug development & registration","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33380/2305-2066-2024-13-1-1462","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
导言。手术后的止痛问题与现代牙科有关,因为疼痛控制是治疗的重要组成部分。除麻醉外,手术后治疗还存在其他问题,如伤口出血和炎症。现代牙科实践中没有一种有针对性的给药系统,也没有一种具有镇痛、消炎、麻醉或止血作用的医疗产品,可以确保患者高度坚持正在进行的切除术后治疗。为了解决这个问题,可以建议开发一种原位植入物--一种直接在注射部位、牙槽窝内形成的剂型。靶向给药系统具有以下优点:无需使用医用敷料;无二次污染风险;剂量准确,可靶向给药至病变部位;对施用部位具有高粘附性;有效成分释放持续时间长等。本综述旨在证实开发一种新的原位植入系统用于牙科切割后实践的可能性和相关性。研究是在主要的出版物数据库(Scopus、Web of Science、PubMed 等)和专利检索数据库中对 2000 年至今出版的资料进行的。该研究描述了目前现有的牙科问题原位系统(可作为直接向牙槽骨输送麻醉剂的系统原型)、用于制造这些系统的聚合物和释放药物的可能性,还描述了现有止痛药物(局部应用和全身作用)与原位系统相比的特点,原位系统具有一定的优势和巨大的发展潜力。根据研究结果,得出了牙科原位植入物药物开发可能性的结论,并确定了最有前途的牙槽相变聚合物。
Relevance of the Development of Dental In situ Implant for Post-resection Therapy (Review)
Introduction. The problem of pain relief after surgery is relevant in modern dentistry, as pain control is an important part of treatment. In addition to anesthesia, there are other problems of post-resection therapy such as bleeding from the wound and inflammation. Modern dental practice does not have a targeted delivery system or a medical product with analgesic, anti-inflammatory, anesthetic or hemostatic action, which ensures high adherence of patients to the ongoing post-resection therapy.Text. To solve this problem, it can be proposed to develop an in situ implant – a dosage form that is formed directly at the injection site, in the alveolar socket. Targeted delivery system has advantages: no need to use a medical dressing material; no risk of secondary contamination; dosing accuracy and target delivery to the lesion locus; high mucoadhesion to the site of application; the duration of the active ingredient release and others. The purpose of the review is to substantiate the possibility and relevance of developing a new in situ implant system for use in dental post-resection practice. The study was conducted on the main databases of publications (Scopus, Web of Science, PubMed and others), and patent search database on materials published from 2000 to the present. The study describes the currently existing in situ systems for dental problems, which could be a prototype of systems for delivering an anesthetic directly to the tooth socket, the polymers used to create them and the possibility of releasing drugs, and also characterizes existing drugs for the pain relief (applied both locally and for systemic action), in comparison with in situ systems, which have certain advantages and great potential for development.Conclusion. Based on the results of the work, a conclusion about the possibility of pharmaceutical development of dental in situ implants was made, and the most promising polymers for phase transition in the alveolar socket were identified.